Patent · US Active

Nucleic acid encoding DLL3 antibodies

US8986972B2 · kind B2 · utility

16Cited by
46References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 22, 2014
Grant dateMar 24, 2015
Priority date—
Expiry dateAug 22, 2034

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/70596
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.